First‐in‐man case of non‐invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure

Radiofrequency catheter ablation (RFCA) is the gold standard therapy for recurrent scar-related ventricular tachycardia (VT), but its efficacy is suboptimal. In patients with advanced heart failure with reduced ejection fraction (HFrEF), RFCA-related potential need for advanced haemodynamic support and periprocedural mortality represent major limiting factors.1 Stereotactic arrhythmia radioablation (STAR) is an emerging non-invasive approach...